Dag-uman, Ernesto D.

HRN: 28-77-49  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
CO-AMOXICLAV 625MG (TAB)
04/04/2026
04/11/2026
PO
625mg
TID
CAP LR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: